Cautious Outlook: Vincent Andrews Issues Sell Rating on Olin Due to Revised EPS and EBITDA EstimatesWe update our estimates for OLN post 4Q24 reporting and lower our PT to $28 from $31. We update our EPS estimates as follows: 1Q25 is revised from $0.17 to - $0.09 (vs. $0.07 consensus), 2025 is revised from $1.47 to $0.49 (vs. $1.72 consensus), 2026 is revised from $2.48 to $1.52 (vs. $3.29 consensus), and 2027 is revised from $2.88 to $1.83 (vs. $4.55 consensus). Accordingly, 1Q25 EBITDA is revised from $205M to $160M (vs. $150M-$170M guide; $185M consensus), 2025 EBITDA is revised from $938M to $780M (vs. $969M consensus), 2026 EBITDA is revised from $1,039M to $925M (vs. $1,180M consensus), and 2027 EBITDA is revised from $1,067M to $963M (vs. $1,331M consensus).